Hidradenitis Suppurativa Global Clinical Trials Review, H1

Products Id :- GDHC2722CTIDB
|
Pages: 99
|
June 2015
|
Region: Global
|

Request for Sample Report

Executive Summary

Hidradenitis Suppurativa Global Clinical Trials Review, H1, 2015

GlobalData's clinical trial report, "Hidradenitis Suppurativa Global Clinical Trials Review, H1, 2015" provides an overview of Hidradenitis Suppurativa clinical trials scenario. This report provides top line data relating to the clinical trials on Hidradenitis Suppurativa. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). Global Data Clinical Trial Reports are generated using Global Data's proprietary database-Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

The report provides a snapshot of the global clinical trials landscape

Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status

The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company

The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment

The Report provides enrollment trends for the past five years

Report provides latest news for the past three months

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons To Buy

Assists in formulating key business strategies with regards to investment

Helps in identifying prominent locations for conducting clinical trials which saves time and cost

Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities

Supports understanding of trials count and enrollment trends by country in global therapeutics market

Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials

Facilitates clinical trial assessment of the indication on a global, regional and country level

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications
ankur [@] kenresearch.com
+91-9015378249
www.kenresearch.com

Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 5

Introduction 6

Hidradenitis Suppurativa 6

Report Guidance 6

Clinical Trials by Region 7

Clinical Trials and Average Enrollment by Country 8

Top Countries Contributing to Clinical Trials in Asia-Pacific 10

Top Five Countries Contributing to Clinical Trials in Europe 11

Top Countries Contributing to Clinical Trials in North America 12

Clinical Trials by G7 Countries: Proportion of Hidradenitis Suppurativa to Dermatology Clinical Trials 13

Clinical Trials by Phase in G7 Countries 14

Clinical Trials in G7 Countries by Trial Status 15

Clinical Trials by E7 Countries: Proportion of Hidradenitis Suppurativa to Dermatology Clinical Trials 16

Clinical Trials in E7 Countries by Trial Status 17

Clinical Trials by Phase 18

In Progress Trials by Phase 19

Clinical Trials by Trial Status 20

Clinical Trials by End Point Status 21

Unaccomplished Trials of Hidradenitis Suppurativa 22

Subjects Recruited Over a Period of Time 23

Clinical Trials by Sponsor Type 24

Prominent Sponsors 25

Top Companies Participating in Hidradenitis Suppurativa Therapeutics Clinical Trials 26

Prominent Drugs 27

Clinical Trial Profiles 28

Clinical Trial Overview of Top Companies 28

AbbVie Inc. 28

Clinical Trial Overview of AbbVie Inc. 28

AstraZeneca Plc 29

Clinical Trial Overview of AstraZeneca Plc 29

Amgen Inc. 30

Clinical Trial Overview of Amgen Inc. 30

Laboratory Corporation of America Holdings 31

Clinical Trial Overview of Laboratory Corporation of America Holdings 31

Laboratoire Labcatal 32

Clinical Trial Overview of Laboratoire Labcatal 32

Janssen Global Services, LLC 33

Clinical Trial Overview of Janssen Global Services, LLC 33

ICON plc 34

Clinical Trial Overview of ICON plc 34

F. Hoffmann-La Roche Ltd. 35

Clinical Trial Overview of F. Hoffmann-La Roche Ltd. 35

Bayer AG 36

Clinical Trial Overview of Bayer AG 36

Abbott Laboratories 37

Clinical Trial Overview of Abbott Laboratories 37

Clinical Trial Overview of Top Institutes / Government 38

Erasmus MC 38

Clinical Trial Overview of Erasmus MC 38

Henry Ford Health System 39

Clinical Trial Overview of Henry Ford Health System 39

ACPM Medical College 40

Clinical Trial Overview of ACPM Medical College 40

Florida Academic Dermatology Centers 41

Clinical Trial Overview of Florida Academic Dermatology Centers 41

Massachusetts General Hospital 42

Clinical Trial Overview of Massachusetts General Hospital 42

New York University School of Medicine 43

Clinical Trial Overview of New York University School of Medicine 43

The Pennsylvania State University 44

Clinical Trial Overview of The Pennsylvania State University 44

University Medical Center Groningen 45

Clinical Trial Overview of University Medical Center Groningen 45

University of Athens 46

Clinical Trial Overview of University of Athens 46

University of California, San Francisco 47

Clinical Trial Overview of University of California, San Francisco 47

Five Key Clinical Profiles 48

Appendix 97

Abbreviations 97

Definitions 97

Research Methodology 98

Secondary Research 98

About GlobalData 99

Disclaimer 99

Source 99

List of Figures

Hidradenitis Suppurativa Therapeutics, Global, Clinical Trials by Region (%), 2015* 7

Hidradenitis Suppurativa Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8

Hidradenitis Suppurativa Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9

Hidradenitis Suppurativa Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015* 11

Hidradenitis Suppurativa Therapeutics Clinical Trials, North America, Top Countries (%), 2015* 12

Proportion of Hidradenitis Suppurativa to Dermatology Clinical Trials, G7 Countries (%), 2015* 13

Hidradenitis Suppurativa Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 14

Hidradenitis Suppurativa Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 15

Proportion of Hidradenitis Suppurativa to Dermatology Clinical Trials, E7 Countries (%), 2015* 16

Hidradenitis Suppurativa Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 17

Hidradenitis Suppurativa Therapeutics, Global, Clinical Trials by Phase (%), 2015* 18

Hidradenitis Suppurativa Therapeutics, Global, Clinical Trials In Progress by Phase, 2015* 19

Hidradenitis Suppurativa Therapeutics, Global, Clinical Trials by Trial Status, 2015* 20

Hidradenitis Suppurativa Therapeutics Clinical Trials, Global, by End Point Status, 2015* 21

Hidradenitis Suppurativa Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 23

Hidradenitis Suppurativa Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015* 24

Hidradenitis Suppurativa Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 25

Hidradenitis Suppurativa Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 26

Hidradenitis Suppurativa Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 27

GlobalData Methodology 98

List of Tables

Hidradenitis Suppurativa Therapeutics, Global, Clinical Trials by Region, 2015* 7

Hidradenitis Suppurativa Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8

Hidradenitis Suppurativa Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9

Hidradenitis Suppurativa Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2015* 10

Hidradenitis Suppurativa Therapeutics Clinical Trials, Europe, Top Five Countries, 2015* 11

Hidradenitis Suppurativa Therapeutics Clinical Trials, North America, Top Countries, 2015* 12

Proportion of Hidradenitis Suppurativa to Dermatology Clinical Trials, G7 Countries (%), 2015* 13

Hidradenitis Suppurativa Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 14

Hidradenitis Suppurativa Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 15

Proportion of Hidradenitis Suppurativa to Dermatology Clinical Trials, E7 Countries (%), 2015* 16

Hidradenitis Suppurativa Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 17

Hidradenitis Suppurativa Therapeutics, Global, Clinical Trials by Phase, 2015* 18

Hidradenitis Suppurativa Therapeutics, Global, Clinical Trials In Progress by Phase 2015* 19

Hidradenitis Suppurativa Therapeutics, Global, Clinical Trials by Trial Status, 2015* 20

Hidradenitis Suppurativa Therapeutics Clinical Trials, Global, by End Point Status, 2015* 21

Hidradenitis Suppurativa Therapeutics, Global, Terminated Clinical Trials, 2015* 22

Hidradenitis Suppurativa Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 23

Hidradenitis Suppurativa Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015* 24

Hidradenitis Suppurativa Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 25

Hidradenitis Suppurativa Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 26

Hidradenitis Suppurativa Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 27

Hidradenitis Suppurativa Therapeutics Clinical Trials Market, Global, Clinical Trials by AbbVie Inc., 2015* 28

Hidradenitis Suppurativa Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca Plc, 2015* 29

Hidradenitis Suppurativa Therapeutics Clinical Trials Market, Global, Clinical Trials by Amgen Inc., 2015* 30

Hidradenitis Suppurativa Therapeutics Clinical Trials Market, Global, Clinical Trials by Laboratory Corporation of America Holdings, 2015* 31

Hidradenitis Suppurativa Therapeutics Clinical Trials Market, Global, Clinical Trials by Laboratoire Labcatal, 2015* 32

Hidradenitis Suppurativa Therapeutics Clinical Trials Market, Global, Clinical Trials by Janssen Global Services, LLC, 2015* 33

Hidradenitis Suppurativa Therapeutics Clinical Trials Market, Global, Clinical Trials by ICON plc, 2015* 34

Hidradenitis Suppurativa Therapeutics Clinical Trials Market, Global, Clinical Trials by F. Hoffmann-La Roche Ltd., 2015* 35

Hidradenitis Suppurativa Therapeutics Clinical Trials Market, Global, Clinical Trials by Bayer AG, 2015* 36

Hidradenitis Suppurativa Therapeutics Clinical Trials Market, Global, Clinical Trials by Abbott Laboratories, 2015* 37

Hidradenitis Suppurativa Therapeutics Clinical Trials Market, Global, Clinical Trials by Erasmus MC, 2015* 38

Hidradenitis Suppurativa Therapeutics Clinical Trials Market, Global, Clinical Trials by Henry Ford Health System, 2015* 39

Hidradenitis Suppurativa Therapeutics Clinical Trials Market, Global, Clinical Trials by ACPM Medical College, 2015* 40

Hidradenitis Suppurativa Therapeutics Clinical Trials Market, Global, Clinical Trials by Florida Academic Dermatology Centers, 2015* 41

Hidradenitis Suppurativa Therapeutics Clinical Trials Market, Global, Clinical Trials by Massachusetts General Hospital, 2015* 42

Hidradenitis Suppurativa Therapeutics Clinical Trials Market, Global, Clinical Trials by New York University School of Medicine, 2015* 43

Hidradenitis Suppurativa Therapeutics Clinical Trials Market, Global, Clinical Trials by The Pennsylvania State University, 2015* 44

Hidradenitis Suppurativa Therapeutics Clinical Trials Market, Global, Clinical Trials by University Medical Center Groningen, 2015* 45

Hidradenitis Suppurativa Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Athens, 2015* 46

Hidradenitis Suppurativa Therapeutics Clinical Trials Market, Global, Clinical Trials by University of California, San Francisco, 2015* 47

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

AbbVie Inc.

AstraZeneca Plc

Amgen Inc.

Laboratory Corporation of America Holdings

Laboratoire Labcatal

Janssen Global Services, LLC

ICON plc

F. Hoffmann-La Roche Ltd.

Bayer AG

Abbott Laboratories

Hidradenitis Suppurativa Clinical Trials, Phase, Completed, Ongoing, Planned, End Points, Trial Locations, Trial Designs, Subjects Recruited, Safety, Efficacy, Bioequivalence, Pharmacokinetics, Pharmacodynamic, Sponsor, Collaborator, CRO's, Terminated, Suspended and Withdrawn trials of Hidradenitis Suppurativa, Pfizer, AstraZeneca, Novartis, GlaxoSmithKline, Sanofi, Eli Lilly and Company, Johnson & Johnson, Merck & Co., Inc, Bristol-Myers Squibb Company, Abbott Laboratories, Hoffmann-La Roche Ltd., Celgene Corporation, Daiichi Sankyo Company, Ltd., Bayer AG, Eisai Inc., GE Healthcare, Biogen Idec Inc., Copharos Inc., Wyeth Pharmaceuticals Inc., National Cancer Center, The University of Texas M. D. Anderson Cancer Center, Vanderbilt Medical Center, Memorial Sloan Kettering Cancer Center, Cancer Research UK, North Central Cancer Group, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Fred Hutchinson Cancer Research Center, European Organization for Research and Treatment of Cancer, Dana-Farber Cancer Institute, The Cancer and Leukemia Group B, Columbia University, UCLA's Jonsson Comprehensive Cancer Center, Case Comprehensive Cancer Center, Mayo Clinic, Duke University, Ohio State University, University of Pennsylvania.

This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ... "Mohit Mittal, Consultant, KPMG Advisory Services"

I am pleased to see the very useful and productive information in the report..Very well structured great presentation reflect professionalism in your research studies.... "Mustafa Masood, Financial Analyst , Coldwell Banker Riyadh"

The Report was very interesting and useful for me... "Marketing Manager, Western Union Business Solutions"

Hidradenitis Suppurativa Global Clinical Trials Review, H1

Wish to Know more

download

For Further Enquiry

apply for job

Know how We Roll

Engage with Us